Kansas City Cancer Center — Overland Park, Kansas

Kansas City Cancer Center is a clinical research site located in Overland Park, Kansas, United States 66210.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Kansas City Cancer Center has participated in 10 clinical trials.

Therapeutic areas: Metastatic Pancreatic Cancer, Breast Cancer, Soft Tissue Sarcoma.

Sponsors: Infinity Pharmaceuticals, Inc., Novartis Pharmaceuticals, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kansas City Cancer Center?

Kansas City Cancer Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kansas City Cancer Center conducted?

Kansas City Cancer Center has 10 clinical trials on record. Their work covers Metastatic Pancreatic Cancer, Breast Cancer, Soft Tissue Sarcoma.

Is Kansas City Cancer Center accredited by Crixeo Health?

Yes — Kansas City Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Kansas City Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.